![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29628-29632, October 15, 1999
From the ¶ Department of Biochemistry and the
University of Iowa Cancer Center, University of Iowa, College of
Medicine, Iowa City, Iowa 52242 and Maspin is a tumor suppressor protein expressed by
normal human mammary epithelium but not by many breast tumor cell
lines. Recombinant human maspin (rMaspin) inhibits tumor cell motility, invasion, and metastasis and thus has potential value as an anti-cancer therapeutic. Maspin is a member of the serpin family and, although the
molecular mechanism by which maspin acts is unknown, recent work
suggests that tissue plasminogen activator is a potential target. A
puzzling observation in previous cell culture studies was loss of
rMaspin activity at higher protein concentrations. One hypothesis to
explain these results is self-association of rMaspin at the higher
concentrations, which would be consistent with the tendency of serpins
to form noncovalent polymers. This hypothesis is addressed by examining
the relationship between rMaspin stability and self-association. Urea
denaturation of rMaspin at pH 7 and 25 °C and at protein
concentrations ranging from 0.01 to 0.2 mg/ml has been monitored by
circular dichroism and intrinsic tryptophan fluorescence. Denaturation
profiles show a protein concentration dependence and indicate the
presence of at least one unfolding intermediate. The results suggest
that destabilization of native monomeric rMaspin leads to partial
unfolding and formation of an intermediate which can
self-associate.
Maspin is a tumor-suppressing protein (Mr
42,138) that was originally identified in normal human breast
epithelial and myoepithelial cells (1). Maspin has subsequently been
localized to epithelial and myoepithelial cells in a variety of tissues
(2). Maspin expression is decreased or lost in most breast carcinoma
cell lines and tissue (1) and its expression is down-regulated in metastatic prostate carcinoma cells as well (3, 4). Overexpression of
maspin in breast carcinoma cell lines leads to decreased cell motility,
invasiveness, and metastasis (1). These results suggest that maspin
plays a key role in inhibiting the progression of breast cancer and,
possibly, prostate cancer.
One very interesting observation with regard to both the mechanism and
possible therapeutic potential of maspin is that addition of exogenous
recombinant maspin (rMaspin)1
to cultured breast carcinoma cells lines leads to decreased cell motility and invasiveness (5-7). These results are in line with recent
studies of conditioned medium from myoepithelial cell cultures: this
medium inhibits motility and invasiveness of breast cancer cells and
these activities are lost after removal of maspin from the medium (8,
9). Naturally occurring maspin and rMaspin thus must act at an
extracellular site or be transported across the plasma membrane to an
intracellular site of action. One possible target for maspin is
tissue-type plasminogen activator (tPA) (10), although there is some
disagreement on this point (11). Nevertheless, the fact that exogenous
rMaspin is active suggests that rMaspin holds promise as a potential
anti-cancer therapeutic.
The inhibitory effect of rMaspin on cancer cell motility and
invasiveness shows a curious dose-response relationship: activity increases with increasing rMaspin concentration up to about 0.2 µM protein and then falls with further increases in
protein concentration (5). One possible explanation for this behavior
may be found in an analogous effect of rMaspin on tPA in
vitro, where concentrations of rMaspin below 0.5 µM
inhibit fibrinogen-activated tPA while higher concentrations stimulate
tPA activity (10). However, a role for tPA in breast cancer cell
motility and invasion has not yet been established. Another hypothesis
to explain the curious concentration dependence of rMaspin activity in
cell culture is self-association of rMaspin (5). This hypothesis is
supported by the fact that maspin belongs to the serpin family and
members of this family show a tendency to self-associate
(e.g. Refs. 12-15).
Self-association of serpins generally involves a structural
feature known as the reactive-site loop (RSL) and one of the three rMaspin does not undergo the S to R transition, but results of
electrophoretic studies suggest that rMaspin self-associates when
subjected to mild perturbations in solution conditions (11). The goal
of the present study is to develop a better understanding of the
relationship between the structure and anti-cancer activity of rMaspin
by focusing more closely on the relationship between stability and
self-association of rMaspin. Urea denaturation of rMaspin at a variety
of protein concentrations has been monitored by circular dichroism (CD)
and fluorescence spectroscopy. The solution structure of rMaspin in the
absence of urea has been investigated by analytical ultracentrifugation
at 25 and 40 °C. Results of the present study demonstrate that
native rMaspin at pH 7.0 is monomeric but that urea denaturation of
rMaspin is a multistate reaction in which an intermediate state
undergoes self-association.
Materials--
rMaspin was purified from Saccharomyces
cerevisiae as described previously (11). rMaspin is >95% pure as
judged by SDS-polyacrylamide gel electrophoresis. Biological activity
of the same batch of rMaspin has been demonstrated in cell culture
studies (7). Crystallized and ultrapure urea was purchased from Roche
Molecular Biochemicals (Indianapolis, IN). All other chemicals were
obtained from Fisher Scientific (Fair Lawn, NJ) or EM Science
(Gibbstown, NJ) and were reagent grade or better. Water was deionized
and glass-distilled. All buffer solutions were passed through 0.45-µm filters and degassed.
Analytical Ultracentrifugation--
Sedimentation equilibrium
experiments were conducted on a Beckman XL-I analytical ultracentrifuge
equipped with a An-60 Ti rotor. Six-channel equilibrium center pieces
were used. Protein concentrations of 9.5 µM (0.4 mg/ml)
and 36 µM (1.5 mg/ml) were examined at pH 5.0, 6.0, and
7.0. The pH 6.0 and 7.0 solutions contained 50 mM sodium
phosphate and 0.1 M NaCl while the pH 5.0 solutions
contained 50 mM sodium acetate and 0.1 M NaCl.
Absorbance was monitored at 280 nm in all samples. Samples at 25 °C
were centrifuged at 10,000, 12,000, and 17,500 rpm and those at
40 °C were centrifuged at 10,000 and 17,500 rpm. These samples were
then subjected to 40,000 rpm to deplete the meniscus of protein, which
facilitates measurement of baseline absorbance values. Data were
analyzed using the ORIGINTM software (version 3.78, Microcal Software, Northampton, MA) supplied with the ultracentrifuge
and running on an IBM PC. The partial specific volume,
Circular dichroism spectropolarimetry--
CD data were acquired
on an AVIV 62DS spectropolarimeter equipped with a thermoelectric
temperature controller. Protein solutions were passed through 0.45-µm
filters and degassed prior to data acquisition. Far-UV CD spectra were
obtained at 25 °C with samples containing 5 mM sodium
phosphate and 4.8 µM (0.20 mg/ml) rMaspin. A 0.1-cm path
length cuvette was used, spectra were collected at 0.5-nm intervals
with an averaging time of 2 s and two scans were averaged.
Fluorescence Spectroscopy--
Fluorescence data were obtained
on a Fluorolog-3 spectrofluorometer (Jobin Yvon-Spex Instruments,
Edison, NJ) equipped with a circulating water bath for temperature
control. Intrinsic tryptophan fluorescence was excited at 295 nm.
Excitation and emission band widths were 2.5 nm, data were collected at
1-nm intervals, and two scans were averaged for each spectrum.
Chemical Denaturation--
Urea denaturation experiments were
done at pH 7.0 with solutions containing 100 mM sodium
phosphate, 1 mM dithiothreitol, 1 mM
Na2-EDTA and the indicated concentration of urea. Buffer solutions containing approximately 9 M urea were prepared
just prior to each experiment and the concentration of urea was
determined by refractometry (20). A concentrated stock solution of
native rMaspin in 100 mM sodium phosphate was diluted into
buffer solutions containing the desired concentrations of urea. When
examining the ability of rMaspin to refold out of concentrated urea,
the stock solution of rMaspin also contained 8 M urea.
The final concentration of protein was the same throughout a
given experiment and was varied from 0.24 µM (0.01 mg/ml)
to 4.8 µM (0.2 mg/ml) between experiments. Samples were
equilibrated at the indicated temperature for approximately 16 h
prior to making spectroscopic measurements. No differences were
observed in experiments where spectroscopic measurements were made
after more extended equilibration. The concentration of rMaspin was
determined using a calculated extinction coefficient for native rMaspin
of 18,450 M
The same protein solutions were used for CD and fluorescence
measurements of urea denaturation. For CD measurements at 222 nm, a
1-cm path length cuvette was used for solutions containing 0.24 and 1.2 µM rMaspin and a 0.2-cm path length cuvette was used for
4.8 µM solutions of rMaspin. The averaging time was
2 s and the reported signal is the mean for data collected over a
2-min period. Fluorescence spectra were acquired as described above. The intensity weighted average emission wavelength (22) was calculated
from emission spectra collected from 305 to 500 nm.
Analytical Ultracentrifugation--
One hypothesis to explain the
loss of rMaspin activity at concentrations greater than 0.2 µM is formation of biologically inactive multimers. This
hypothesis was tested using equilibrium analytical ultracentrifugation.
The results suggest that, in the absence of other contributing factors,
the hypothesis may be incorrect: at pH 7.0, native rMaspin is monomeric
at concentrations approaching 20 µM at both 25 and
40 °C (Fig. 1). Solutions containing
higher concentrations of rMaspin show clear evidence for non-ideality (data not shown), leading to apparent molecular weights that are less
than expected on the basis of sequence data.
In cell culture studies, the pH of the medium declines over time as a
consequence of cellular metabolism. To investigate the possibility that
such a decrease in pH leads to self-association of rMaspin, the protein
was subjected to analytical ultracentrifugation at more acidic pH. The
results at pH 6 are similar to those seen at pH 7: native rMaspin is
monomeric (Fig. 1). At pH 5 and 25 °C, rMaspin forms a visible
precipitate at all concentrations and the solutions are not suitable
for quantitative analysis of sedimentation behavior. Acidic pH thus
leads to self-association of rMaspin. However, the pH of cell culture
medium is not likely to fall below pH 6, so we conclude that
acidification of cell culture medium is not sufficient to drive
self-association of rMaspin.
Chemical Denaturation--
The centrifugation experiments were
conducted in simple phosphate or acetate buffer solutions containing
100 mM NaCl, while cell culture medium contains a host of
other components that may contribute to self-association of
rMaspin. Results of previous studies demonstrated that rMaspin is
indeed capable of undergoing self-association at moderately acidic or
basic pH, or at pH 7.4 and temperatures greater than 40 °C (11).
However, these studies explored a relatively small set of solution
conditions, so chemical denaturation has been used in the present study
to obtain a more complete and precise understanding of rMaspin
stability and self-association.
Urea denaturation of rMaspin at concentrations ranging from 0.24 to 4.8 µM has been monitored by both far-UV CD at 222 nm (Fig. 2A) and intrinsic
tryptophan fluorescence (Fig. 2B) at pH 7 and 25 °C. The
urea denaturation profiles monitored by CD and fluorescence are in
qualitative agreement on two major points: the denaturation profiles
are sensitive to protein concentration and at least two distinct
transitions are observed at rMaspin concentrations >0.24
µM. The chemical denaturation of rMaspin must thus
involve at least three states: native (N), an intermediate (I), and the
denatured or unfolded (U) state.
The ultracentrifugation experiments show that N is monomeric in these
solution conditions, so the protein concentration dependence must
result from self-association of the I or U states. The transition from
I to U is stabilized against urea denaturation by increasing protein
concentration. This suggests that I undergoes self-association to a
greater extent than U. Further evidence for self-association of I is
found in the fluorescence data: the Rayleigh scattering peak increases
in intensity at urea concentrations between the two transitions and
returns to relatively low values upon completion of the second
transition (data not shown).
The simplest model that is consistent with the data is as
follows,
Ideally, least squares analysis of the denaturation profiles would be
used to obtain estimates for the thermodynamics of rMaspin denaturation
and self-association. In the case of rMaspin, this type of analysis is
confounded at present by a lack of knowledge concerning the
stoichiometry of self-association and by incomplete reversibility of
denaturation: dilution of rMaspin out of 8 M urea only
leads to partial recovery of the spectroscopic signals (Fig.
3). The extent of recovery depends on
protein concentration, so the irreversible reaction involves
self-association of rMaspin.
The stability of rMaspin has been measured at 37 °C to
investigate the possibility that partial unfolding and self-association are more likely at the temperature of cell culture studies. Urea denaturation of 1.2 µM rMaspin at pH 7.0 and 37 °C
(Fig. 4) shows at least two interesting
differences relative to data obtained at 25 °C. First, the midpoint
of the initial transition occurs at a lower urea concentration, about
1.6 M at 37 °C versus about 1.9 M
at 25 °C, suggesting that native rMaspin is less stable at the
higher temperature. Second, the midpoint of the second transition
occurs at a higher urea concentration, about 3.5 M versus approximately 3 M at 25 °C. The
partially unfolded and multimeric I state of rMaspin is thus stabilized
at the higher temperature. Overall, rMaspin is more likely to undergo
partial unfolding and self-association at 37 °C than at
25 °C.
CD Spectra--
The conformational changes associated with the
denaturation and self-association of rMaspin have been investigated by
CD and fluorescence. Urea denaturation monitored by far-UV CD suggests that the transition from N to I involves a significant loss of secondary structure (Fig. 2A). Comparison of far-UV CD
spectra in the presence and absence of urea further substantiates this conclusion (Fig. 5A).
In the absence of urea, the CD spectrum is dominated by a minimum at
about 222 nm and a maximum at 196 nm. A molecular model for native
rMaspin has been generated on the basis of its homology to ovalbumin
(23). The predicted secondary structure content is approximately 30%
helix, 30%
rMaspin in 8 M urea has no detectable secondary
structure as measured by CD (Fig. 5A). The CD spectrum under
conditions where the intermediate, I, is well populated suggests a loss
of secondary structure relative to N, as judged by the general decrease
in intensity. Estimates for the secondary structure content of I are
difficult because absorbance by urea precludes measurements below 207 nm, but the data suggest that a significant loss of helical structure
occurs in the transition from N to I.
Fluorescence Spectra--
The fluorescence spectrum for
rMaspin reports primarily on the environment of its two tryptophan
residues, Trp-171 and Trp-258 (25). The wavelength of maximum emission
intensity,
The partial unfolding of N to I is associated primarily with small
changes in fluorescence intensity and, possibly, a very modest red
shift of Chemical denaturation of rMaspin is a multistep process involving
at least one intermediate, I, in addition to the native, N, and
unfolded species, U. The spectral properties of U are consistent with a
disordered polypeptide backbone and tryptophan residues that are well
exposed to solvent. The denaturation profile is sensitive to protein
concentration and this appears to result from self-association of I. Fluorescence data suggest that one or both of the tryptophan residues
are buried in both N and I, but CD data indicate that I contains much
less secondary structure than N. Much of the change in secondary
structure appears to be loss of helix.
Detailed structural information is available for a small number
of equilibrium unfolding intermediates in other proteins. The
intermediates show native-like structure in a portion of the molecule
while the rest of the protein is largely disordered (26). On this
basis, the molecular model for native rMaspin can be used to generate
hypotheses regarding possible structure in the I state.
All serpins of known structure share a very similar overall fold
(16). A model for the structure of maspin has been constructed on the
basis of significant sequence identity with a serpin of known
structure, ovalbumin (23, 27). The fold is dominated by the extensive
The transition from N to I in rMaspin is accompanied by changes in
tryptophan fluorescence intensity and an almost negligible red shift in
The fluorescence and far-UV CD spectra for the I state are very similar
to those for equilibrium and kinetic intermediates in the folding of
ovalbumin (28), although no self-association was observed in these
studies. Lomas and co-workers (15) have recently illuminated the
relationship between partial unfolding and self-association of
Experimental and computational studies of multidomain proteins suggest
that the cooperativity of denaturation reflects the properties of
interfaces between domains (34-36). One hypothesis that follows from
this analysis is that more cooperative transitions are observed in
serpins that have more extensive interdomain interactions. This
hypothesis may be testable with the rapidly growing data base of serpin
structures (16).
In the case of rMaspin, the cooperativity of denaturation also reflects
self-association of an intermediate, I. In fact, CD and fluorescence
spectra for I (Fig. 5) are probably dominated by contributions from
multimeric I species. Self-association of intermediate states may also
explain the three-state chemical denaturation profiles observed for
other serpins (29-33).
Does self-association of rMaspin explain its unusual dose-response
behavior in studies of breast cancer cell motility and invasiveness?
Native rMaspin does not self-associate but partially unfolded rMaspin
undergoes self-association at concentrations where decreases in
biological activity are observed. However, native rMaspin appears
to be relatively stable at pH 7 and 37 °C (Fig. 4). These results
suggest that, under the solution conditions examined in the present
study, rMaspin does not self-associate to a significant extent. In
principle, questions remain regarding the possible effect of other cell
medium components on self-association. Indirect evidence indicates the
real potential for such an effect: self-association of rMaspin appears
to be induced by a chromogenic peptide substrate for
plasmin.2
An alternative approach will be to examine the possibility that peptide
bond cleavage in the RSL of rMaspin leads to self-association with
intact rMaspin. rMaspin is very prone to partial proteolysis in the RSL
(11, 23). Cultures of breast cancer cells accumulate proteinases (8),
some of which may cleave the RSL of rMaspin. Little is known about the
stability and self-association properties of RSL-cleaved rMaspin
relative to intact rMaspin (11).
We thank Cammon Arrington and
William Forsyth for assistance in preparation of the figures.
We also thank them and Dr. Richard Seftor for careful reading of the manuscript.
*
This work was supported in part by National Institutes of
Health Grants GM46869 (to A. D. R.) and S10 RR10409 (for
purchase of an analytical ultracentrifuge).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: BioMarin Pharmaceuticals, 46 Gali Dr., Novato, CA 94949.
2
T. Liu, P. A. Pemberton, and A. D. Robertson, unpublished results.
The abbreviations used are:
rMaspin, recombinant
maspin;
RSL, reactive-site loop;
tPA, tissue-type plasminogen
activator.
Three-state Unfolding and Self-association of Maspin, a
Tumor-suppressing Serpin*
§, and
LXR Biotechnology,
Richmond, California 94804
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-sheets, A through C, found in all serpins (16). The RSL of one
molecule can insert into either the A or C sheet of another molecule
(12). A related intramolecular association occurs between the RSL and the A-sheet of many serpins as part of an extraordinary conformational change from a metastable biologically active state (also
known as the stressed or S state) to a more stable latent state (also
known as the relaxed or R state).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, of rMaspin was calculated to be 0.716 ml/g on
the basis of amino acid composition (17). The calculated solution
density,
, for the pH 5.0, 6.0, and 7.0 samples was 1.004, 1.007, and 1.008 g/ml, respectively (18). The apparent molecular weight of
rMaspin, M, was determined by fitting absorbance, A, as a function of radial position, r, to the
following equation for an ideal solution containing a single species
(19),
where r0 is the radial position of the
meniscus,
(Eq. 1)
is the angular velocity of the rotor, R is the
gas constant, T is the absolute temperature, and
A0 is the baseline absorbance in the absence of protein.
1 cm
1 at 280 nm
(21).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Equilibrium analytical ultracentrifugation of
rMaspin at 0.4 mg/ml and pH 6.0 and 7.0. The temperature was
40 °C and other solution conditions are as described in the text.
Data are indicated by the small circles and smooth
lines in the center panel are the results of fits to
Equation 1. These data were collected at 17,500 rpm. For the pH 7.0 data, the fitted molecular weight is 40,200 ± 900 and
A0 = 0.003. The data at pH 6.0 yield a molecular
weight of 37,800 ± 500 and A0 = 0.004. The
predicted molecular weight based on amino acid composition is 42,138. Residuals of the fit are shown in the upper and lower
panels for pH 6.0 and 7.0, respectively.

View larger version (17K):
[in a new window]
Fig. 2.
Urea denaturation of rMaspin at pH 7.0 and
25 °C monitored by CD at 222 nm (A) and intrinsic
tryptophan fluorescence (B).
[
]222 is the mean residue ellipticity at 222 nm.
Fluorescence data are reported as intensity averaged emission
wavelength (22). Solutions were prepared and data were acquired as
described under "Experimental Procedures." Concentrations of
rMaspin are 0.24 µM (×), 1.2 µM (
), and
4.8 µM (
). Fluorescence intensity at 0.24 µM rMaspin was insufficient for data analysis.
where n is the stoichiometry of the association
reaction, which is not yet known. The square brackets
indicate an equilibrium between monomeric and multimeric I
that could be either on or off the direct pathway for unfolding. In
either case, this model predicts that the transition from N to I should
occur at lower urea concentrations with increasing protein
concentration. This is not evident from the CD data in Fig.
2A, but changes in the transition midpoints may be masked by
the complexity of the denaturation profiles.
(Eq. 2)

View larger version (15K):
[in a new window]
Fig. 3.
Refolding (
) of 4.8 µM rMaspin from 8 M urea at pH 7.0 and 25 °C monitored by CD (A)
at 222 nm and intrinsic fluorescence (B). The
data for unfolding of 4.8 µM rMaspin (
) are the same
as in Fig. 2 and are shown for comparison. All other details are as
described in the legend to Fig. 2.

View larger version (15K):
[in a new window]
Fig. 4.
Urea denaturation of rMaspin at pH 7.0 and
37 °C (
) monitored by CD at 222 nm (B) and
intrinsic fluorescence (B). The concentration of
rMaspin is 1.2 µM. Data collected at 25 °C (
) are
shown for comparison. All other details are as described in the legend
to Fig. 2.

View larger version (23K):
[in a new window]
Fig. 5.
A, far-UV circular dichroism spectra of
4.8 µM rMaspin at 25 °C and pH 7.0 in 5 mM
sodium phosphate alone, labeled 0 M, and in the presence of
2.3 and 8 M urea. B, fluorescence emission
spectra of rMaspin under the same solution conditions. Intensity is in
arbitrary units (a.u.), as recorded. Experimental details
are as described under "Experimental Procedures."
-strand, 10%
-turn, with the balance in irregular
structure. These values have been used as input into Equation 11 of
Yang and co-workers (24) to predict mean residue ellipticities for
native rMaspin. Predicted values of
12,000 and +20,000
deg·cm2 dmol
1 at 222 and 196 nm,
respectively, are similar to the observed values of
12,500
deg·cm2 dmol
1 and +16,000
deg·cm2 dmol
1. CD data are thus consistent
with the homology model for rMaspin.
max, for native rMaspin is 343 nm and this
shifts to 358 nm when rMaspin is denatured in 8 M urea
(Fig. 5B). The latter value is as expected for
solvent-exposed tryptophan side chains. The blue-shifted
max for native rMaspin indicates that one or both of the
tryptophan side chains is at least partially buried in the nonpolar
interior of native rMaspin.
max (Fig. 5B). Thus, the environment
of the tryptophan residues appears to be undergoing relatively modest changes in the transition from N to I. In contrast,
max
undergoes a significant red shift in the transition from I to U,
suggesting that buried tryptophan residues are exposed to solvent in
this transition.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-sheet A, which bridges two major domains. One domain is rich in
structure and includes the RSL while the other domain consists of mixed
/
structure. Sequence alignment suggests that Trp-171 and Trp-258
of maspin correspond to Trp-184 and Trp-267 of ovalbumin. Both
tryptophan residues are located in the domain that is rich in
structure.
max. This suggests that the tertiary structure in the
-rich domain is largely intact in I. In contrast, the far-UV CD data
suggest a significant loss of helical structure. Most of the helical
structure is located in a mixed
/
domain that is distal to the
RSL. These observations lead to the hypothesis that I consists of a
partially disordered
/
domain and a largely intact
-rich
domain. Self-association of I may result from exposure of hydrophobic
surfaces in the partially folded molecule or from insertion of the RSL
into either
-sheet A or C, which appears to be the case for a number
of other serpins (e.g. Refs. 14 and 15).
1-antitrypsin. More generally, the three-state chemical
denaturation profile for rMaspin closely resembles those for other
serpins such as
1-antitrypsin, antithrombin III,
1-antichymotrypsin, C1 inhibitor, and plasminogen
activator inhibitor I (29-33). Ovalbumin is a clear exception in this
regard and undergoes a more cooperative two-state unfolding reaction
(29). For serpins that have undergone the S to R transition, chemical
denaturation profiles are shifted toward higher denaturant
concentrations and, in some cases, appear to reflect two-state
transitions (29, 31).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel. 319-335-6515;
Fax: 319-335-9570; E-mail: andy-robertson@uiowa.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Zou, Z.,
Anisowicz, A.,
Hendrix, M. J. C.,
Thor, A.,
Neveu, M.,
Sheng, S.,
Rafidi, K.,
Seftor, E.,
and Sager, R.
(1994)
Science
263,
526-529 2.
Pemberton, P. A.,
Tipton, A. R.,
Pavloff, N.,
Smith, J.,
Erickson, J. R.,
Mouchabeck, Z. M.,
and Kiefer, M. C.
(1997)
J. Histochem. Cytochem.
45,
1697-1706 3.
Zhang, M.,
Magit, D.,
and Sager, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5673-5678 4.
Umekita, Y.,
Hiipakka, R. A.,
and Liao, S.
(1997)
Cancer Lett.
113,
87-93[CrossRef][Medline]
[Order article via Infotrieve]
5.
Sheng, S.,
Pemberton, P. A.,
and Sager, R.
(1994)
J. Biol. Chem.
269,
30988-30993 6.
Sheng, S.,
Carey, J.,
Seftor, E. A.,
Dias, L.,
Hendrix, M. J. C.,
and Sager, R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11669-11674 7.
Seftor, R. E. B.,
Seftor, E. A.,
Sheng, S.,
Pemberton, P. A.,
Sager, R.,
and Hendrix, M. J. C.
(1998)
Cancer Res.
58,
5681-5685 8.
Sternlicht, M. D.,
Kedeshian, P.,
Shao, Z.-M.,
Safarians, S.,
and Barsky, S. H.
(1997)
Clin. Cancer Res.
3,
1949-1953[Abstract]
9.
Shao, Z. M.,
Nguyen, M.,
Alpaugh, M. L.,
O'Connell, J. T.,
and Barsky, S. H.
(1998)
Exp. Cell Res.
241,
394-403[CrossRef][Medline]
[Order article via Infotrieve]
10.
Sheng, S.,
Truong, B.,
Frederickson, D.,
Wu, R.,
Pardee, A. B.,
and Sager, R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
499-504 11.
Pemberton, P. A.,
Wong, D. T.,
Gibson, H. L.,
Kiefer, M. C.,
Fitzpatrick, P. A.,
Sager, R.,
and Barr, P. J.
(1995)
J. Biol. Chem.
270,
15832-15837 12.
Stein, P. E.,
and Carrell, R. W.
(1995)
Nature Struct. Biol.
2,
96-113[CrossRef][Medline]
[Order article via Infotrieve]
13.
Mikus, P.,
and Ny, T.
(1996)
J. Biol. Chem.
271,
10048-10053 14.
Carrell, R. W.,
and Gooptu, B.
(1998)
Curr. Opin. Struct. Biol.
8,
799-809[CrossRef][Medline]
[Order article via Infotrieve]
15.
Dafforn, T. R.,
Mahadeva, R.,
Elliott, P. R.,
Sivasothy, P.,
and Lomas, D. A.
(1999)
J. Biol. Chem.
274,
9548-9555 16.
Whisstock, J.,
Skinner, R.,
and Lesk, A. M.
(1998)
Trends Biochem. Sci.
23,
63-67[CrossRef][Medline]
[Order article via Infotrieve]
17.
Zamyatin, A. A.
(1984)
Annu. Rev. Biophys. Bioeng.
13,
145-165[CrossRef][Medline]
[Order article via Infotrieve]
18.
Laue, T. M.,
Shah, B. D.,
Ridgeway, T. M.,
and Pelletier, S. L.
(1992)
in
Analytical Ultracentrifugation in Biochemistry and Polymer Science
(Harding, S. E.
, Rowe, A. J.
, and Horton, J. C., eds)
, pp. 91-125, The Royal Society of Chemistry, Cambridge
19.
Hansen, J. C.,
Lebowitz, J.,
and Demeler, B.
(1994)
Biochemistry
33,
13155-13163[CrossRef][Medline]
[Order article via Infotrieve]
20.
Pace, C. N.
(1986)
Methods Enzymol.
131,
266-280[Medline]
[Order article via Infotrieve]
21.
Pace, C. N.,
Vajdos, F.,
Fee, L.,
Grimsley, G.,
and Gray, T.
(1995)
Protein Sci.
4,
2411-2423[Abstract]
22.
Royer, C. A.,
Mann, C. J.,
and Matthews, C. R.
(1993)
Protein Sci.
2,
1844-1852[Abstract]
23.
Fitzpatrick, P. A.,
Wong, D. T.,
Barr, P. J.,
and Pemberton, P. A.
(1996)
Protein Eng.
9,
585-589 24.
Yang, J. T.,
Wu, C.-S.,
and Martinez, H. M.
(1986)
Methods Enzymol.
130,
208-269[Medline]
[Order article via Infotrieve]
25.
Eftink, M. R.
(1995)
Methods Enzymol.
259,
487-512[Medline]
[Order article via Infotrieve]
26.
Raschke, T. M.,
and Marqusee, S.
(1998)
Curr. Opin. Biotech.
9,
80-86[CrossRef][Medline]
[Order article via Infotrieve]
27.
Stein, P. E.,
Leslie, A. G.,
Finch, J. T.,
and Carrell, R. W.
(1991)
J. Mol. Biol.
221,
941-959[CrossRef][Medline]
[Order article via Infotrieve]
28.
Onda, M.,
Tatsumi, E.,
Takahashi, N.,
and Hirose, M.
(1997)
J. Biol. Chem.
272,
3973-3979 29.
Bruch, M.,
Weiss, V.,
and Engel, J.
(1988)
J. Biol. Chem.
263,
16626-16630 30.
Hervé, M.,
and Ghélis, C.
(1990)
Eur. J. Biochem.
191,
653-658[Medline]
[Order article via Infotrieve]
31.
Powell, L. M.,
and Pain, R. H.
(1992)
J. Mol. Biol.
224,
241-252[CrossRef][Medline]
[Order article via Infotrieve]
32.
Wang, Z.,
Mottonen, J.,
and Goldsmith, E. J.
(1996)
Biochemistry
35,
16443-16448[CrossRef][Medline]
[Order article via Infotrieve]
33.
Lee, K. N.,
Im, H.,
Kang, S. W.,
and Yu, M.-H.
(1998)
J. Biol. Chem.
273,
2509-2516 34.
Freire, E.,
and Murphy, K. P.
(1991)
J. Mol. Biol.
222,
687-698[CrossRef][Medline]
[Order article via Infotrieve]
35.
Freire, E.,
Murphy, K. P.,
Sanchez-Ruiz, J. M.,
Galisteo, M. L.,
and Privalov, P. L.
(1992)
Biochemistry
31,
250-256[CrossRef][Medline]
[Order article via Infotrieve]
36.
Allewell, N. M.
(1993)
Trends Biochem. Sci.
18,
1-2[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Onda, K. Nakatani, S. Takehara, M. Nishiyama, N. Takahashi, and M. Hirose Cleaved Serpin Refolds into the Relaxed State via a Stressed Conformer J. Biol. Chem., June 20, 2008; 283(25): 17568 - 17578. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Cabrita, J. A. Irving, M. C. Pearce, J. C. Whisstock, and S. P. Bottomley Aeropin from the Extremophile Pyrobaculum aerophilum Bypasses the Serpin Misfolding Trap J. Biol. Chem., September 14, 2007; 282(37): 26802 - 26809. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cella, A. Contreras, K. Latha, J. M. Rosen, and M. Zhang Maspin is physically associated with {beta}1 integrin regulating cell adhesion in mammary epithelial cells FASEB J, July 1, 2006; 20(9): 1510 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Al-Ayyoubi, P. G. W. Gettins, and K. Volz Crystal Structure of Human Maspin, a Serpin with Antitumor Properties: REACTIVE CENTER LOOP OF MASPIN IS EXPOSED BUT CONSTRAINED J. Biol. Chem., December 31, 2004; 279(53): 55540 - 55544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Casares, M. Sadqi, O. Lopez-Mayorga, F. Conejero-Lara, and N. A. J. van Nuland Detection and Characterization of Partially Unfolded Oligomers of the SH3 Domain of {alpha}-Spectrin Biophys. J., April 1, 2004; 86(4): 2403 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. McGowen, H. Biliran Jr., R. Sager, and S. Sheng The Surface of Prostate Carcinoma DU145 Cells Mediates the Inhibition of Urokinase-type Plasminogen Activator by Maspin Cancer Res., September 1, 2000; 60(17): 4771 - 4778. [Abstract] [Full Text] |
||||
![]() |
M. C. Pearce, H. Rubin, and S. P. Bottomley Conformational Change and Intermediates in the Unfolding of alpha 1-Antichymotrypsin J. Biol. Chem., September 8, 2000; 275(37): 28513 - 28518. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |